Molecular Breast Imaging

The future of Molecular Breast Imaging is low dose and 3D

Breast cancer represents 12% of new cancer cases and 25% of all cancers in women. Mammography is the most common modality used for breast imaging. Between 25% and 50% of women (depending on country and ethnic origins) have dense breast tissue, which limits mammography sensitivity.

Molecular Breast Imaging (MBI) is a test that uses a radioactive tracer and special cameras to find breast cancer. Rather than taking a picture of the breast, MBI is a type of functional imaging, meaning that the picture created shows difference in the activity of tissue.